Skip to content

Adapted Fencing in Breast Cancer: a Pilot Study

Physical and Moral Benefits of Adapted Fencing in Patients With Invasive Breast Cancer: Pilot Study of a Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04627714
Acronym
RIPOSTE
Enrollment
24
Registered
2020-11-13
Start date
2021-11-10
Completion date
2022-11-30
Last updated
2022-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasms

Keywords

Breast, Neoplams, adapted physical activity

Brief summary

Literature have shown the benefit of practicing regular physical activity during and after cancer treatment, particularly in terms of improving quality of life. The French Fencing Federation has thus developed an adapted physical activity program (Solution RIPOSTE) specially intended for patients with breast cancer. Adapted fencing sessions (saber) are thus offered to these patients in a perfectly secure context (i.e. compulsory medical-sports evaluation and trained fencing master). Since 2016, this RIPOSTE program has been implemented in several fencing halls in Lorraine. Our research project (controlled, randomized trial) aims to assess the impact of the practice of adapted fencing on the quality of life of patients, the functional capacities of the operated side (shoulder) and on the reduction of the sides effects of treatments. Our hypothesis is that such an adapted fencing program improves quality of life as well as functional abilities.

Interventions

OTHERAdapted Physical Activity

Intervention consists in 1h30/week of adapted fencing

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be a woman * ≥ 18 years old. * Have undergone unilateral breast surgery for primary invasive breast cancer * Time between surgery and inclusion between 2 to 4 weeks after surgery * Accept and be able to complete self-administered questionnaires * Satisfy the prior medico-sports evaluation * Be affiliated to a social security scheme or beneficiary of such a scheme * Have received full information on the organization of the research and have signed their informed consent.

Exclusion criteria

* Presence of bone metastases, especially vertebral * Presence of a contraindication to the practice of fencing during the medico-sports evaluation (post-surgery period that is too painful and / or requiring specific treatment in rehabilitation) * Refusal to participate in the study * Woman of childbearing age who does not have effective contraception. * Persons referred to Articles L.1121-5, L.1121-7 and L. 1121-8 of the Public Health Code * Pregnant woman, parturient or nursing mother * Minor (non-emancipated) * Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice) * Person of full age unable to express consent * Persons deprived of their liberty by a judicial or administrative decision, persons undergoing psychiatric treatment under Articles L. 3212-1 and L. 3213-1.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline score of Quality of Life Questionnaire Core 30 (QLQ-C30) at 3 months.Baseline (J0) and at 3 months (M3)Questionnaire. 30 items. minimum value = 30. Maximum value = 120. A high score means a worse outcome (i.e. poor quality of life)

Secondary

MeasureTime frameDescription
Change from baseline score of Disabilities of the Arm, Shoulder and Hand measurement tool (DASH) at 3 monthsBaseline (J0) and at 3 months (M3)Questionnaire. 30 items. The score ranges from 0 (no disability) to 100 (most severe disability).
Change from baseline score of Multidimensional Fatigue Inventory (MFI-20) at 3 monthsBaseline (J0) and at 3 months (M3)Questionnaire. 20 items. Minimal value = 20. Maximal value = 100. A high score means a worse outcome (i.e. high level of fatigue)
Change from baseline score of Hospital Anxiety and Depression Scale at 3 months.Baseline (J0) and at 3 months (M3)Questionnaire. 14 items. The score ranges from 0 to 100. a high score means a worse outcome (i.e. high level of anxiety and depression)

Countries

France

Contacts

Primary ContactMathias POUSSEL, MD, PhD
m.poussel@chru-nancy.fr0383155520

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026